Cytokinetics

06/10/2026

Every June 2, Major League Baseball Players Association (MLB) celebrates Lou Gehrig Day to raise awareness and funds for research.

was proud to honor Gehrig's legacy, patients, and families alongside both the Philadelphia Phillies at Citizens Bank Park, and the San Francisco Giants at Oracle Park on June 8.

As an annual sponsor of these games, Cytokinetics remains deeply inspired and dedicated to supporting everyone impacted by ALS.

06/08/2026

Applications are open for the 2026 Cytokinetics Corporate Giving Program! True to our values, we prioritize giving back to our communities.

The program provides charitable donations to eligible non-profit organizations in the United States to support equitable healthcare initiatives for cardiovascular disease, science education and certain essential services for local and at-risk communities.

We’re accepting applications through August 3. Learn more and apply at https://bit.ly/4jo4s7g

05/20/2026

Today is International Clinical Trials Day, a moment to recognize the power of clinical research and the people who make it possible.

Watch the video to hear how clinical research professionals at Cytokinetics keep patients at the heart of every study.

05/07/2026

The impact of hypertrophic cardiomyopathy (HCM) can go beyond physical health, affecting emotional wellbeing, too. During , we recognize the full impact of and stand with those navigating its challenges.

04/29/2026

It’s Heart Failure Awareness Days across Europe. Together, let’s shine a light on heart failure and deepen understanding.

Find information and educational resources here: https://bit.ly/3RCQ7Zv

04/20/2026

This National Volunteer Week, we’re recognizing our employees who give their time to support our communities. Together, we're helping advance meaningful change and strengthen the organizations working to make our world a better place.

Thank you to the partners and organizations in our communities striving for positive change. Your work truly makes a difference.

Learn more about our community engagement: https://bit.ly/4ijSuNe

04/16/2026

It was an honor to host such an insightful discussion. We’re grateful to have had the opportunity to elevate patient perspectives with HCM during the opening of our new Zug office.

Thank you for being a part of this milestone. Together, we’re working toward a future with more treatment options and better support for the European HCM community.

It was an honor to be invited for the opening of the new European office of Cytokinetics in Zug, Switzerland, and speak about patient experiences with HCM.

03/20/2026

We were proud to attend the American Heart Association Bay Area Research Roundtable again this year — an event that brings together leaders across the life sciences industry to advance progress against heart disease.

As a Presenting Sponsor, Cytokinetics joined fellow supporters to help raise awareness of cardiovascular disease, fundraise for the American Heart Association, and highlight the importance of improving access to care.

03/10/2026

Decades of research have helped illuminate how diseases like alter the heart muscle at the molecular level. As pioneers in muscle biology, we’ve contributed to the advancement of understanding this disease, and how it may be treated.

In this sponsored article from Scientific American, Fady Malik and James Hartman share insights into our drug discovery approach and the science behind targeting cardiac muscle function.

In a decades-long effort, researchers have discovered how to tweak the molecular pathways that turn heart muscle motors up or down

02/25/2026

Today for HCM Awareness Day our Patient Advocacy Team highlights a critical reality: HCM is often an invisible disease. While people living with HCM may look healthy on the outside, their hearts are working harder than anyone can see.

That’s why we are dedicated to raising awareness today and every day.